anthranilamide has been researched along with tariquidar in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catalano, C; Gaudreault, RC; Labrie, P; Lacroix, J; Lee, DK; Maddaford, SP; Rakhit, S | 2 |
2 other study(ies) available for anthranilamide and tariquidar
| Article | Year |
|---|---|
In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity at CYP-450.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Resistance, Multiple; Humans; ortho-Aminobenzoates; Quinolines; Structure-Activity Relationship | 2006 |
In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2).
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Assay; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Intestines; ortho-Aminobenzoates; Pyrazines; Quinolines | 2007 |